| Followers | 19 |
| Posts | 6606 |
| Boards Moderated | 1 |
| Alias Born | 05/23/2019 |
Thursday, November 23, 2023 1:01:34 AM
WQLF SAYS; This is for our IHUB Resident CVSI Basher JIMMINNY John Smith Pocahontas Pinocchio CRICKGET over at the CVSI Yahoooooo Board. YQU Know, the one who claims that he isn’t posting over yonder YQU Understand. Have a Happier CVSI Thanksgiving Day. Have Mercy Have Partners Have Reverse Triangular Merger Have Patience Have Faith WQLF Ahooooooo
Dr. Joong J Fang Said; A Question for Elon Musk. How many aliases does one really need to bash CVSI in order to spew misinformation?/b]
https://einvestingforbeginners.com/sec-form-4-daah-2/
”If that subject interests you, please click the link below for more detail on the derivative securities transaction codes”
Derivative Security Transaction Codes
Dr. Joong J Fang Said; A Question for Elon Musk. How many aliases does one really need to bash CVSI in order to spew misinformation?/b]
https://einvestingforbeginners.com/sec-form-4-daah-2/
”If that subject interests you, please click the link below for more detail on the derivative securities transaction codes”
Derivative Security Transaction Codes
Bullish
Recent CVSI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:10:09 PM
- CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results • ACCESS Newswire • 05/14/2026 08:00:00 PM
- CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026 • ACCESS Newswire • 05/12/2026 10:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
